JUL 6, 2026 · JOURNAL ARTICLE
Reframing SGLT2 inhibition as systematic metabolic stress modulation across the cardiovascular-renal-metabolic axis
Exploration of Cardiology
A structured narrative review synthesizing evidence from RCTs, meta-analyses, and mechanistic studies to establish a conceptual framework and therapeutic recommendations for SGLT2 inhibitor use across cardiovascular-renal-metabolic conditions.
Reported
Study periodJanuary 2016 to December 2025